Kintara Therapeutics, Inc. (DMPI) [Rocket]

In millions, except per share items	Mar-31-23	Dec-31-22	Sep-30-22	Jun-30-22	Mar-31-22	Dec-31-21	Sep-30-21	Jun-30-21
	10-Q	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K
Revenues	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Cost of goods sold	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Gross profit	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Selling, general and administrative [+]	16.9	19.0	21.4	22.7	23.9	25.2	22.1	17.6
Sales and marketing	11.4	13.5	15.9		17.2	18.5	12.6
General and administrative				5.5				11.0
Other operating expenses	-1.8	-1.8	-1.7	-1.6	1.3	1.4	1.5	0.0
EBIT [+]	-15.1	-17.2	-19.7	-21.1	-25.2	-26.5	-26.1	-21.5
EBIT growth	-40.3%	-35.2%	-24.6%	-2.1%	67.3%	155.3%	707.1%	8382.9%
Non-recurring items				1.6				16.6
Interest expense								0.0
Interest expense								0.0
Other income (expense), net	-0.1	-0.1	-0.1	0.0	-0.2	-0.2	-0.2	-0.1
Pre-tax income	-16.8	-18.9	-21.3	-22.7	-23.9	-25.2	-24.7	-38.3
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-16.8	-18.9	-21.3	-22.7	-23.9	-25.2	-24.8	-41.5

Basic EPS [+]	($0.54)	($0.61)	($0.69)	($1.07)	($1.54)	($1.12)	($0.87)	($1.71)
Growth	-65.3%	-45.7%	-20.6%	-37.6%	-36.0%	-56.2%	-67.4%	90.8%
Diluted EPS [+]	($0.54)	($0.61)	($0.69)	($1.07)	($1.54)	($1.12)	($0.87)	($1.71)
Growth	-65.3%	-45.7%	-20.6%	-37.6%	-36.0%	-56.2%	-67.4%	90.8%

Shares outstanding (basic) [+]	31.3	31.1	31.0	21.2	15.5	22.6	28.6	24.3
Growth	101.6%	37.7%	8.4%	-12.5%	-23.9%	41.7%	126.9%	138.0%
Shares outstanding (diluted) [+]	31.3	31.1	31.0	21.2	15.5	22.6	28.6	24.3
Growth	101.6%	37.7%	8.4%	-12.5%	-23.9%	41.7%	126.9%	138.0%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.